skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 
Home » UK Shares » Three Quick Facts » Three Quick Facts: TruFin, ITM Power and Yourgene Health

Three things you need to know in the financial markets this morning from investment writer, Tony Cross.

TruFin

Fintech incubator TruFin [LON:TRU] has published its final results today for the year to December 31st. Although the company posted pre-tax losses of £8.4m off revenues of just £14.8m, the note adds that many of the investments made in recent years are now starting to yield fruit. Highlights here included news that revenues for Q1 are 20% up on last year, whilst Oxygen Finance has posted 4 consecutive quarters of EBITDA profitability.

ITM Power

There’s a short note from ITM Power [LON:ITM] out this morning regarding the sale of an electrolyser to Austria. It’s the company’s first play into the country but perhaps more critically, once purified, the hydrogen generated will be used in the production of semiconductors. That means the chemical can be generated onsite, rather than having to be shipped in on trailers. No details of the size of the sale are included.

Yourgene Health

AIM listed biotech play Yourgene Health [LON:YGEN] has this morning announced it has been successful in winning a place on the government’s national framework for COVID testing. This will see the company tendering for part of a £3bn piece of work, but the note adds that there’s no guarantee that any contract will be forthcoming or indeed if part of the tender is won, how much this will be worth.

Sign up for three quick facts and more with our Free Daily Digest newsletter, every weekday morning.

This article is not investment advice. Investors should do their own research or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we follow most closely. They represent significant growth stories in our view. Our in-depth reports detail why we like them.

Comments

Subscribe for more stories like this, 8am weekdays - for free!


Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

Pepperstone
FP Markets
IG
Spreadex
WisdomTree
ActivTrades
Back To Top